Foghorn Therapeutics Inc. Quarterly Current Ratio in % from Q2 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Foghorn Therapeutics Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q2 2024.
  • Foghorn Therapeutics Inc. Current Ratio for the quarter ending June 30, 2024 was 472 %, a 21.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 472 -130 -21.6% Jun 30, 2024
Q1 2024 460 -217 -32.1% Mar 31, 2024
Q4 2023 501 -253 -33.6% Dec 31, 2023
Q3 2023 559 -274 -32.9% Sep 30, 2023
Q2 2023 601 -259 -30.1% Jun 30, 2023
Q1 2023 677 -196 -22.5% Mar 31, 2023
Q4 2022 755 -132 -14.9% Dec 31, 2022
Q3 2022 833 -48 -5.45% Sep 30, 2022
Q2 2022 861 +67.3 +8.48% Jun 30, 2022
Q1 2022 873 Mar 31, 2022
Q4 2021 887 Dec 31, 2021
Q3 2021 881 Sep 30, 2021
Q2 2021 794 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.